Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0184
EDITORIAL
|
Standard and Research for Ovarian Cancer: Emphasis on interactome-based tests for screening or treatment including HIPEC?
|
Dimosthenis Ziogas, MD, PhD
|
Affiliation: Dimosthenis Ziogas MD, PhD, Dept. of Surgery, University of Ioannina, School of Medicine, 45110 Ioannina, Greece.
E-mail: deziogas@hotmail.com |
ABSTRACT
Ovarian cancer is often diagnosed late with poor prognosis. Current and emerging research is focused on proteomics-based development of robust tests for screening the general population and standardization of treatment including hyperthermic intraperitoneal chemotherapy. Progress, limitations and challenges in identifying high-risk women for development of ovarian cancer and multidisciplinary treatment are discussed.
(Citation: Gastric & Breast Cancer 2011; 10(3): 146-150)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €33 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
